​

Merck (MRK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MRK Stock Forecast

Merck (MRK) stock forecast, based on 32 Wall Street analysts, predicts a 12-month average price target of $125.00, with a high of $148.00 and a low of $106.00. This represents a 57.89% increase from the last price of $79.17.

$75 $90 $105 $120 $135 $150 High: $148 Avg: $125 Low: $106 Last Closed Price: $79.17

MRK Stock Rating

Merck stock's rating consensus is Buy, based on 32 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 25 Buy (78.12%), 6 Hold (18.75%), 1 Sell (3.12%), and 0 Strong Sell (0.00%).

Buy
Total 32 1 6 25 Strong Sell Sell Hold Buy Strong Buy

MRK Price Target Upside V Benchmarks

TypeNameUpside
StockMerck57.89%
SectorHealthcare Stocks 35.46%
IndustryDrug Manufacturers - General Stocks40.29%

Price Target Trends

1M3M12M
# Anlaysts-111
Avg Price Target-$106.00$136.18
Last Closing Price$79.17$79.17$79.17
Upside/Downside-33.89%72.01%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 254119--24
Mar, 255129--26
Feb, 255147--26
Jan, 255168--29
Dec, 246167--29
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 05, 2025Terence FlynnMorgan Stanley$106.00$90.7416.82%33.89%
Dec 02, 2024Courtney BreenBernstein$110.00$100.699.25%38.94%
Nov 15, 2024Akash TewariJefferies$148.00$98.3650.47%86.94%
Nov 01, 2024Evan David SeigermanBMO Capital$136.00$101.8833.49%71.78%
Oct 09, 2024Trung HuynhUBS$136.00$108.8824.91%71.78%
Oct 07, 2024Carter GouldBarclays$140.00$109.7727.54%76.83%
Aug 15, 2024Akash TewariJefferies$147.00$113.4929.53%85.68%
Jul 31, 2024Colin BristowUBS$142.00$112.8925.79%79.36%
Jul 31, 2024Geoff MeachamBank of America Securities$145.00$115.2125.86%83.15%
Jun 12, 2024Mohit BansalWells Fargo$140.00$131.056.83%76.83%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 05, 2025Goldman SachsBuyBuyhold
Dec 02, 2024BernsteinMarket PerformMarket Performhold
Nov 15, 2024JefferiesBuyBuyhold
Nov 01, 2024Leerink PartnersOutperformOutperformhold
Oct 17, 2024BernsteinMarket Performinitialise
Oct 09, 2024UBSBuyBuyhold
Oct 07, 2024BarclaysOverweightOverweighthold
Sep 16, 2024Wells FargoBuyBuyhold
Sep 13, 2024NeedhamHoldHoldhold
Sep 03, 2024Cowen & Co.BuyBuyhold

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.79$5.16$5.73$0.14$6.74----
Avg Forecast$5.72$5.79$7.39$1.38$7.76$9.23$10.03$10.74$10.74
High Forecast$5.88$5.96$7.71$1.46$7.87$10.03$11.36$12.56$11.28
Low Forecast$5.56$5.63$7.17$1.33$7.64$7.89$8.36$8.52$10.51
Surprise %-51.22%-10.88%-22.46%-89.86%-13.14%----

Revenue Forecast

$40B $48B $56B $64B $72B $80B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$41.52B$48.70B$59.28B$60.12B$64.17B----
Avg Forecast$48.19B$48.52B$59.12B$59.97B$63.99B$67.11B$70.95B$74.43B$75.50B
High Forecast$49.25B$49.59B$61.06B$60.30B$64.28B$68.80B$71.14B$74.90B$78.42B
Low Forecast$47.14B$47.46B$57.78B$59.81B$63.75B$66.44B$70.77B$73.97B$74.24B
Surprise %-13.84%0.38%0.27%0.24%0.28%----

Net Income Forecast

$0 $7B $14B $21B $28B $35B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.07B$13.05B$14.52B$365.00M$17.12B----
Avg Forecast$5.03B$12.27B$14.91B$365.00M$19.76B$21.95B$24.45B$26.84B$27.37B
High Forecast$6.91B$14.72B$17.89B$438.00M$20.06B$25.55B$28.92B$32.00B$28.74B
Low Forecast$3.15B$9.81B$11.93B$292.00M$19.46B$20.09B$21.30B$21.71B$26.77B
Surprise %40.57%6.36%-2.62%--13.37%----

MRK Forecast FAQ

Is Merck stock a buy?

Merck stock has a consensus rating of Buy, based on 32 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 25 Buy, 6 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Merck is a favorable investment for most analysts.

What is Merck's price target?

Merck's price target, set by 32 Wall Street analysts, averages $125 over the next 12 months. The price target range spans from $106 at the low end to $148 at the high end, suggesting a potential 57.89% change from the previous closing price of $79.17.

How does Merck stock forecast compare to its benchmarks?

Merck's stock forecast shows a 57.89% upside, outperforming the average forecast for the healthcare stocks sector (35.46%) and outperforming the drug manufacturers - general stocks industry (40.29%).

What is the breakdown of analyst ratings for Merck over the past three months?

  • April 2025: 16.67% Strong Buy, 45.83% Buy, 37.50% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 19.23% Strong Buy, 46.15% Buy, 34.62% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 19.23% Strong Buy, 53.85% Buy, 26.92% Hold, 0% Sell, 0% Strong Sell.

What is Merck’s EPS forecast?

Merck's average annual EPS forecast for its fiscal year ending in December 2025 is $9.23, marking a 36.94% increase from the reported $6.74 in 2024. Estimates for the following years are $10.03 in 2026, $10.74 in 2027, and $10.74 in 2028.

What is Merck’s revenue forecast?

Merck's average annual revenue forecast for its fiscal year ending in December 2025 is $67.11B, reflecting a 4.58% increase from the reported $64.17B in 2024. The forecast for 2026 is $70.95B, followed by $74.43B for 2027, and $75.5B for 2028.

What is Merck’s net income forecast?

Merck's net income forecast for the fiscal year ending in December 2025 stands at $21.95B, representing an 28.26% increase from the reported $17.12B in 2024. Projections indicate $24.45B in 2026, $26.84B in 2027, and $27.37B in 2028.